Pharmacokinetics and Disposition of Momelotinib Revealed a Disproportionate Human Metabolite—Resolution for Clinical DevelopmentJim Zheng, Jeffrey A. Silverman, John Ling et al.|Drug Metabolism and Disposition|2018Cited by 56
Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous InfusionElijah Weber, Renu Singh, Raju Subramanian et al.|Clinical Pharmacokinetics|2024Cited by 17
Human and nonclinical disposition of [<sup>14</sup>C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infectionRaju Subramanian, Bill J. Smith, Heather Zhang et al.|Xenobiotica|2022Cited by 7